Evidence map›Paper›PMID 3320093›Full record

ReviewJournal of clinical pathology1987

Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature.

P A Hall, A J D'Ardenne

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of clinical pathology, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Synthesis of LewisCarbohydrate research · 2017
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Vimentin expression by Reed-Sternberg cells in Hodgkin's disease.Virchows Archiv. A, Pathological anatomy and histopathology · 1992
    Article
  16. Article
  17. Article
  18. Article
  19. Anti-vimentin antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.Virchows Archiv. A, Pathological anatomy and histopathology · 1990
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

P A HallDepartment of Histopathology, St Bartholomew's Hospital, London.
A J D'Ardenne
St Bartholomew's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of antibodies of CD15 as diagnostic markers of Hodgkin's disease was assessed from a review of the literature. A total of 571 cases of Hodgkin's disease and 386 cases of non-Hodgkin's lymphoma were included. The sensitivity of CD15 in detecting cases of Hodgkin's disease was 80% or 91% if cases of lymphocyte predominant Hodgkin's disease were excluded. The specificity of CD15 was only 80.6%, or in other words, 19.4% of cases of non-Hodgkin's lymphoma were CD15 positive. In an ideal test both the sensitivity and specificity would be 100% and if the test performance were no better than chance then they would both be 50%. It is concluded that CD15 immunostaining cannot be regarded as a sensitive or specific marker of Hodgkin's disease. Application of this formal method of analysis to other immunohistological reagents and panels of antibodies is discussed.

Indexed as

Antibodies, MonoclonalAntibody SpecificityAntigens, DifferentiationHodgkin DiseaseHumansLymphoma, Non-HodgkinAntibodies, MonoclonalAntigens, Differentiation

Identifiers

PMID3320093
PMCPMC1141228
OpenAlexW2060774649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.